Holding on to Sirtex

Sirtex Medical's share price has increased 47% this year, and almost 200% since we first upgraded it in Sirtex enters remission on 8 Nov 10 (Speculative buy – $5.90). Sirtex looks very expensive on traditional valuation metrics, but to call it overvalued is risky. On one hand the maker of liver cancer treatments is growing rapidly and its SIRFLOX study could significantly increase its market share (see Sirtex targets growing market from 14 Mar 14 (Hold – $15.56)). On the other hand, expectations for the business are high and there's always the threat of a superior treatment rendering Sirtex's treatments...

Sirtex Medical's share price has increased 47% this year, and almost 200% since we first upgraded it in Sirtex enters remission on 8 Nov 10 (Speculative buy – $5.90). Sirtex looks very expensive on traditional valuation metrics, but to call it overvalued is risky.

{{content.question}}

Mastercard

{{ twilioFailed ? 'SMS Code Failed to Send…' : 'An SMS verification code has been sent ...' }}

Hi {{ user.FirstName }}

Looks like you have already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to complete your SMS verification

We cannot send you a code via SMS to {{user.DayPhone}}

If you didn't receive SMS code please

SMS code cannot be sent due to: {{ twilioStatus }}

Please select one of the options below:

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device


Verify your mobile number to proceed…

Please check your mobile number below and press the Send Verification Code button. This will be used to complete your verification in the next step.

Please sign up for full access

Mastercard

Updating information

Please wait ...

Trial

Mastercard
{{ productPrice }} / day
( GST included )
Price $0
GST $0
Discount -{{productDiscount}}
TOTAL {{productPrice}}
  • Mastercard
  • Visa

Please click on the ACTIVATE button to finalise your membership

Mastercard

The email address you entered is registered with InvestSMART.

Please login or select "Don't know password"

Please untick this box when using a public or shared device


Register as a new member

(using a different email)

Related Articles